Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MEDI-573 |
Trade Name | |
Synonyms | Dusigitumab |
Drug Descriptions |
Dusigitumab (MEDI-573) is an antibody that targets IGF-1 and IGF-2, resulting in decreased IGF-mediated signaling and potentially leading to decreased tumor growth (PMID: 25193511). |
DrugClasses | IGF1/2 Antibody 2 |
CAS Registry Number | 1204390-13-5 |
NCIT ID | C82683 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MEDI-573 | MEDI-573 | 0 | 0 |
MEDI-573 + Sirolimus | MEDI-573 Sirolimus | 0 | 0 |
MEDI-573 + Vistusertib | MEDI-573 Vistusertib | 0 | 0 |